Skip to main content
SpringerLink
Log in

Supportive Care for Patients with Leukemia: A Historical Perspective

  • Chapter
  • First Online:
Neoplastic Diseases of the Blood

  • 2182 Accesses

Abstract

There have been remarkable scientific and technical advancements which have dramatically improved the management of patients receiving intensive treatments for acute leukemia and other hematologic malignancies such that treatment failure due to bleeding and infection is now uncommon. The history of the development of these approaches to the prevention and treatment of infections, hemorrhage and nausea and vomiting will be reviewed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk Kooy M, Verdonck LF, Beck J, Döhner H, Gratwohl A, Pabst T, Verhoef G, Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON), German AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med. 2009;361:1235–48.

    Article  PubMed  Google Scholar 

  2. Murphy S, Schiffer CA, Katz AJ. Platelet concentrates: functional considerations, storage, and quality control. J Clin Apher. 1983;1:185–9.

    Article  CAS  PubMed  Google Scholar 

  3. Murphy S, Gardner FH. Room temperature storage of platelets. Transfusion. 1976;16:2–3.

    Article  CAS  PubMed  Google Scholar 

  4. Hogge DE, Thompson BW, Schiffer CA. Platelet storage for 7 days in second-generation blood bags. Transfusion. 1986;26:131–5.

    Article  CAS  PubMed  Google Scholar 

  5. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857–61.

    Article  CAS  PubMed  Google Scholar 

  6. Schiffer CA, Lee EJ, Ness PM, Reilly J. Clinical evaluation of platelet concentrates stored for one to five days. Blood. 1986;67:1591–4.

    CAS  PubMed  Google Scholar 

  7. Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Alloimmunization following platelet transfusion: the absence of a dose-response relationship. Blood. 1981;57:395–8.

    CAS  PubMed  Google Scholar 

  8. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol. 1977;2:219–26.

    Article  CAS  PubMed  Google Scholar 

  9. Duquesnoy RJ, Testin J, Aster RH. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients. Transplant Proc. 1977;9:1829–31.

    CAS  PubMed  Google Scholar 

  10. Schiffer CA, O’Connell B, Lee EJ. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood. 1989;74:1172–6.

    CAS  PubMed  Google Scholar 

  11. Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res. 1965;25:1516–20.

    CAS  PubMed  Google Scholar 

  12. Nusbacher J, Scher ML, MacPherson JL. Plateletpheresis using the haemonetics model 30 cell separator. Vox Sang. 1977;33:9–15.

    Article  CAS  PubMed  Google Scholar 

  13. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337:1861–9.

    Article  Google Scholar 

  14. Daly PA, Schiffer CA, Aisner J, Wiernik PH. A comparison of platelets prepared by the Haemonetics model 30 and multiunit bag plateletpheresis. Transfusion. 1979;19:778–81.

    Article  CAS  PubMed  Google Scholar 

  15. O’Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood. 1992;79:527–31.

    PubMed  Google Scholar 

  16. Freedman J, Hooi C, Garvey MB. Prospective platelet crossmatching for selection of compatible random donors. Br J Haematol. 1984;56:9–18.

    Article  CAS  PubMed  Google Scholar 

  17. Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol. 1983;14:363–9.

    Article  CAS  PubMed  Google Scholar 

  18. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med. 1994;331:625–8.

    Article  CAS  PubMed  Google Scholar 

  19. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962;266:905–9.

    Article  CAS  PubMed  Google Scholar 

  20. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med. 1997;337:1870–5.

    Article  CAS  PubMed  Google Scholar 

  21. Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H. Safety and cost effectiveness of a 10 × 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 1998;91:3601–6.

    CAS  PubMed  Google Scholar 

  22. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet. 1991;338:1223–6.

    Article  CAS  PubMed  Google Scholar 

  23. Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, TOPPS Investigators, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013;368:1771–80.

    Article  CAS  PubMed  Google Scholar 

  24. Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Study Alliance Leukemia, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomized study. Lancet. 2012;380:1309–16.

    Article  PubMed  Google Scholar 

  25. Schiffer CA. They took a mulligan, and mostly got it right…the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation. Transfusion. 2014;54:2372–4.

    Article  PubMed  Google Scholar 

  26. Schiffer CA, Bohlke K, Delaney M, Goldstein MA, Hume H, Magdalinski AJ, McCullough JJ, Omel JL, Rainey JM, Rebulla P, Rowley SD, Troner MB, Anderson KC. Platelet Transfusion for Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017.; (In Press)

    Google Scholar 

  27. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O’Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AA, AABB. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162:205–13.

    Article  PubMed  Google Scholar 

  28. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328–40.

    Article  CAS  PubMed  Google Scholar 

  29. Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971;284:1061–5.

    Article  CAS  PubMed  Google Scholar 

  30. Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med. 1982;97:503–8.

    Article  CAS  PubMed  Google Scholar 

  31. Schimpff SC. Laminar air flow room reverse isolation and microbial suppression to prevent infection in patients with cancer. Cancer Chemother Rep. 1975;59:1055–60.

    CAS  PubMed  Google Scholar 

  32. Bodey GP, Loftis J, Bowen E. Protected environment for cancer patients. Effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy. Arch Intern Med. 1968;122:23–30.

    Article  CAS  PubMed  Google Scholar 

  33. Bodey GP, Gehan EA, Freireich EJ, Frei E 3rd. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci. 1971;262:138–51.

    Article  CAS  PubMed  Google Scholar 

  34. Hahn DM, Schimpff SC, Fortner CL, Smyth AC, Young VM, Wiernik PH. Infection in acute leukemia patients receiving oral nonabsorbable antibiotics. Antimicrob Agents Chemother. 1978;13:958–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wade JC, de Jongh CA, Newman KA, Crowley J, Wiernik PH, Schimpff SC. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis. 1983;147:624–34.

    Article  CAS  PubMed  Google Scholar 

  36. Wade JC, Schimpff SC, Hargadon MT, Fortner CL, Young VM, Wiernik PH. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med. 1981;304:1057–62.

    Article  CAS  PubMed  Google Scholar 

  37. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases mycoses study group. N Engl J Med. 1999;340:764–71.

    Article  CAS  PubMed  Google Scholar 

  38. Walsh TJ. Echinocandins—an advance in the primary treatment of invasive candidiasis. N Engl J Med. 2002;347:2070–2.

    Article  PubMed  Google Scholar 

  39. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391–402.

    Article  CAS  PubMed  Google Scholar 

  40. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356:348–59.

    Article  CAS  PubMed  Google Scholar 

  41. McCredie KB, Freireich EJ, Hester JP, Vallejos C. Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch. Transfusion. 1974;14:357–64.

    Article  CAS  PubMed  Google Scholar 

  42. Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci. 1964;113:1081–9.

    Article  CAS  PubMed  Google Scholar 

  43. Schiffer CA, Aisner J, Dutcher JP, Wiernik PH. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol. 1983;15:65–74.

    Article  CAS  PubMed  Google Scholar 

  44. Alavi JB, Root RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, Guerry D, Schreiber AD, Shaw JM, Koch P, Cooper RA. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977;296:706–11.

    Article  CAS  PubMed  Google Scholar 

  45. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975;292:761–6.

    Article  CAS  PubMed  Google Scholar 

  46. Herzig RH, Herzig GP, Graw RG Jr, Bull MI, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med. 1977;296:701–5.

    Article  CAS  PubMed  Google Scholar 

  47. Dutcher JP, Schiffer CA, Johnston GS, Papenburg D, Daly PA, Aisner J, Wiernik PH. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood. 1983;62:354–60.

    CAS  PubMed  Google Scholar 

  48. Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH. Alloimmunization following prophylactic granulocyte transfusion. Blood. 1979;54:766–74.

    CAS  PubMed  Google Scholar 

  49. Bensinger WI, Price TH, Dale DC, Clift R, Lilleby K, Williams B, Thomas ED, Buckner CD. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81:1883–8.

    CAS  PubMed  Google Scholar 

  50. Wade JC, Gaffey M, Wiernik PH, Schimpff SC, Schiffer CA, Wesley M, Hoofnagle JH. Hepatitis in patients with acute nonlymphocytic leukemia. Am J Med. 1983;75:413–22.

    Article  CAS  PubMed  Google Scholar 

  51. Alter HJ. Discovery of the non-a, non-B hepatitis virus: the end of the beginning or the beginning of the end. Transfus Med Rev. 1989;3:77–81.

    Article  CAS  PubMed  Google Scholar 

  52. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood. 1991;78:246–50.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R., HWCRB 4th Floor, Detroit, MI, 48201, USA

    Charles A. Schiffer M.D.

Authors
  1. Charles A. Schiffer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles A. Schiffer M.D. .

Editor information

Editors and Affiliations

  1. Cancer Research Foundation, Chappaqua, New York, USA

    Peter H. Wiernik

  2. Cancer Research Foundation, Chappaqua, New York, USA

    Janice P. Dutcher

  3. Department of Hematology, Mayo Clinic Department of Hematology, Rochester, Minnesota, USA

    Morie A. Gertz

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Schiffer, C.A. (2018). Supportive Care for Patients with Leukemia: A Historical Perspective. In: Wiernik, P., Dutcher, J., Gertz, M. (eds) Neoplastic Diseases of the Blood. Springer, Cham. https://doi.org/10.1007/978-3-319-64263-5_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64263-5_48

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64262-8

  • Online ISBN: 978-3-319-64263-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation